MDI-403
MDI-403 is a retinoic acid receptor (RAR) agonist with an EC50 value of less than 1 μM. MDI-403 exhibits significant antiviral activity against SARS-CoV-2, and can dose-dependently inhibit the expression of viral nucleoprotein (NP) and reduce the proportion of infected cells. MDI-403 mainly acts during the virus invasion stage. MDI-403 can be used in research on anti-SARS-CoV-2.
For research use only. We do not sell to patients.
- CAS No.: 127471-94-7
- Formula: C29H36O4
- Molecular Weight:448.59
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
Chemical Information
-
CAS No. 127471-94-7
-
Molecular Weight 448.59
-
Formula C29H36O4
-
SMILES
C(=C/C(=C/C=C/C(=C\C(OCC(=O)C1=CC=C(OC)C=C1)=O)/C)/C)\C=2C(C)(C)CCCC2C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
MDI-403 Related Classifications
HY-W816575 Related Classifications
Powered by Bioz
Keywords
- MDI-403
- 127471-94-7
- MDI403
- MDI 403
- RAR/RXR
- SARS-CoV
- Retinoic acid receptors
- Retinoid X receptors
- SARS coronavirus
- SARS-CoV-2
- drug repurposing
- ReFRAME library
- antiviral compounds
- RAR agonist
- high-throughput screening
- viral replication inhibition
- Vero E6 cells
- dose-response
- synergy with remdesivir
- Inhibitor
- inhibitor
- inhibit